Clinicopathological predictors of finding additional inguinal lymph node metastases in penile cancer patients after positive dynamic sentinel node biopsy: a European multicentre evaluation

To develop a predictive model for additional inguinal lymph node metastases (LNM) at inguinal lymph node dissection (ILND) after positive dynamic sentinel node biopsy (DSNB) using DSNB characteristics to identify a patient group in which ILND might be omitted.

[1]  H. Putter,et al.  Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Glas,et al.  70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age. , 2021, The Lancet. Oncology.

[3]  M. Abufaraj,et al.  Is There an Oncological Benefit of Performing Bilateral Pelvic Lymph Node Dissection in Patients with Penile Cancer and Inguinal Lymph Node Metastasis? , 2021, Journal of clinical medicine.

[4]  H. Augustin,et al.  Emerging paradigms in metastasis research , 2020, The Journal of experimental medicine.

[5]  P. Ascierto,et al.  Evolving impact of long-term survival results on metastatic melanoma treatment , 2020, Journal for ImmunoTherapy of Cancer.

[6]  H. G. van der Poel,et al.  Hybrid Indocyanine Green-99mTc-nanocolloid for Single-photon Emission Computed Tomography and Combined Radio- and Fluorescence-guided Sentinel Node Biopsy in Penile Cancer: Results of 740 Inguinal Basins Assessed at a Single Institution. , 2020, European urology.

[7]  M. S. van der Heijden,et al.  Management of the penile squamous cell carcinoma patient after node positive radical inguinal lymph node dissection: current evidence and future prospects. , 2019, Current opinion in urology.

[8]  D. van Klaveren,et al.  Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool , 2019, Journal of surgical oncology.

[9]  G. Guimarães,et al.  External validation of nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes , 2019, International braz j urol : official journal of the Brazilian Society of Urology.

[10]  A. Nica,et al.  Sentinel lymph nodes in vulvar cancer: Management dilemmas in patients with positive nodes and larger tumors. , 2017, Gynecologic oncology.

[11]  Daya Luo,et al.  Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis , 2017, Molecular Cancer.

[12]  A. Gesierich,et al.  Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.

[13]  S. Michopoulou,et al.  Investigating the role of SPECT/CT in dynamic sentinel lymph node biopsy for penile cancers , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  J. B. Jensen,et al.  DaPeCa‐1: diagnostic accuracy of sentinel lymph node biopsy in 222 patients with penile cancer at four tertiary referral centres – a national study from Denmark , 2016, BJU International.

[15]  Sophia K Apple,et al.  Sentinel Lymph Node in Breast Cancer: Review Article from a Pathologist’s Point of View , 2016, Journal of pathology and translational medicine.

[16]  P. Spiess,et al.  Establishing Criteria for Bilateral Pelvic Lymph Node Dissection in the Management of Penile Cancer: Lessons Learned from an International Multicenter Collaboration. , 2015, The Journal of urology.

[17]  E. van Werkhoven,et al.  Prophylactic pelvic lymph node dissection in patients with penile cancer. , 2015, The Journal of urology.

[18]  R. Mansel,et al.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. , 2014, The Lancet. Oncology.

[19]  D. Raggi,et al.  The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience. , 2014, The Journal of urology.

[20]  H. G. van der Poel,et al.  Contemporary management of regional nodes in penile cancer-improvement of survival? , 2014, The Journal of urology.

[21]  Cees Lucas,et al.  Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis. , 2013, European urology.

[22]  C. Corbishley,et al.  Dynamic sentinel lymph node biopsy in patients with invasive squamous cell carcinoma of the penis: a prospective study of the long-term outcome of 500 inguinal basins assessed at a single institution. , 2013, European urology.

[23]  E. Steyerberg,et al.  [Regression modeling strategies]. , 2011, Revista espanola de cardiologia.

[24]  R. Verhoeven,et al.  Incidence trends and survival of penile squamous cell carcinoma in the Netherlands , 2011, International journal of cancer.

[25]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[26]  A. Eggermont,et al.  Clinical relevance of melanoma micrometastases (<0.1 mm) in sentinel nodes: are these nodes to be considered negative? , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  H. V. van Boven,et al.  Size of metastasis in the sentinel node predicts additional nodal involvement in penile carcinoma. , 2006, The Journal of urology.

[28]  M. Gallee,et al.  Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. , 2005, The Journal of urology.

[29]  F. Algaba,et al.  EAU guidelines on penile cancer. , 2002, European urology.

[30]  C. Pettaway,et al.  Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience. , 2002, The Journal of urology.

[31]  J. Kulkarni,et al.  Prophylactic bilateral groin node dissection versus prophylactic radiotherapy and surveillance in patients with N0 and N1-2A carcinoma of the penis. , 1994, European urology.